JP Morgan Chase’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
VCM
ZDA
JP Morgan Chase's WGS Position: Q1 2026 in Review
JP Morgan Chase increased its GeneDx Holdings (WGS) stake by 24% in Q1 2026, buying an estimated $595K and bringing the position to 33,674 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #4095.
JP Morgan Chase first reported a position in WGS in Q4 2020 and has held it in 19 quarters since. The position peaked at $8.29M in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.
- JP Morgan Chase held 33,674 shares of GeneDx Holdings worth $2.01M as of Q1 2026.
- JP Morgan Chase bought 6,526 GeneDx Holdings shares in Q1 2026, an estimated $595K.
- GeneDx Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4095 holding.
- JP Morgan Chase first reported a position in GeneDx Holdings in Q4 2020 and has held it in 19 quarters since.
- JP Morgan Chase's GeneDx Holdings position peaked at $8.29M in Q4 2024.
- 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.